Understanding the genesis and treatment of DN is facilitated by the availability of hyperglycemic, obese, db/db mice in which there is a spontaneous point mutation in the leptin receptor (Lepr) leading to a loss of receptor signaling. The gene discussed is LEPR; the disease is liver dysplastic nodule.